期刊文献+

Characteristics of sildenafil erections in healthy young men 被引量:2

Characteristics of sildenafil erections in healthy young men
下载PDF
导出
摘要 Aim: To determine the effect of sildenafil citrate on the nocturnal penile erections (i.e. time to onset, the duration of erection, and the interval between first and second erections) of healthy young men. Methods: Twenty-two potent men, 23-29 years old, were recruited for the study. All subjects completed three sessions over consecutive nights using the RigiScan monitoring device (Dacomed, Minneapolis, USA). After a first night of adaptation, night 2 records were their baseline values, and on night 3 they received 100 mg of sildenafil citrate. Statistical comparisons were done between the second and third night data. Results: The mean time to onset of the first erection with sildenafil citrate was (34 ± 18) min, whereas it was (74 ± 24) min (P 〈 0.001) without sildenafil citrate. The number of erections observed during the first 5 h after sildenafil citrate medication was 3.6 ± 0.5 in contrast to 2.4 ± 0.5 with no medica- tion (P = 0.001). The interval between first and second erections was shorter with sildenafil citrate: (52 ± 26) min vs. (85 ± 34) min (P = 0.01). The duration of the last erection was statistically significantly longer with the sildenafil citrate: (64 ± 33) min vs. (42 ± 28) min (P 〈 0.01). Conclusion: Healthy young men achieved erection within 34 min after sildenafil citrate administration, which is shorter than the 1 h interval proposed by the manufacturer. The interval between the first and second erections was shorter and the duration of the last nocturnal erection was longer. Aim: To determine the effect of sildenafil citrate on the nocturnal penile erections (i.e. time to onset, the duration of erection, and the interval between first and second erections) of healthy young men. Methods: Twenty-two potent men, 23-29 years old, were recruited for the study. All subjects completed three sessions over consecutive nights using the RigiScan monitoring device (Dacomed, Minneapolis, USA). After a first night of adaptation, night 2 records were their baseline values, and on night 3 they received 100 mg of sildenafil citrate. Statistical comparisons were done between the second and third night data. Results: The mean time to onset of the first erection with sildenafil citrate was (34 ± 18) min, whereas it was (74 ± 24) min (P 〈 0.001) without sildenafil citrate. The number of erections observed during the first 5 h after sildenafil citrate medication was 3.6 ± 0.5 in contrast to 2.4 ± 0.5 with no medica- tion (P = 0.001). The interval between first and second erections was shorter with sildenafil citrate: (52 ± 26) min vs. (85 ± 34) min (P = 0.01). The duration of the last erection was statistically significantly longer with the sildenafil citrate: (64 ± 33) min vs. (42 ± 28) min (P 〈 0.01). Conclusion: Healthy young men achieved erection within 34 min after sildenafil citrate administration, which is shorter than the 1 h interval proposed by the manufacturer. The interval between the first and second erections was shorter and the duration of the last nocturnal erection was longer.
出处 《Asian Journal of Andrology》 SCIE CAS CSCD 2005年第4期395-398, ,共4页 亚洲男性学杂志(英文版)
关键词 sildenafil citrate nocturnal erection nocturnal penile tumescence rigidity testing erectile dysfunction sildenafil citrate nocturnal erection nocturnal penile tumescence rigidity testing erectile dysfunction
  • 相关文献

参考文献12

二级参考文献39

  • 1Wimpie I.Pangkahila.Evaluation of transurethral application of alprostadil for erectile dysfunction in Indonesians[J].Asian Journal of Andrology,2000,2(3):233-236. 被引量:1
  • 2Antonio Aversa,Andrea Fabbri.New oral agents for erectile dysfunction: what is changing in our practice?[J].Asian Journal of Andrology,2001,3(3):175-179. 被引量:4
  • 3Medina P, Segarra G, Vila JM, Domenech C, Martinez-Leon JB, Lluch S. Effects of sildenafil on human penile blood vessels.Urology 2000; 56: 539-43.
  • 4Kaplan SA, Reis RB, Kohn IJ, Ikeguchi EF, Laor E, Te AE, et al. Safety and efficacy of sildenafil in postmenopausal women with sexual dysfunction. Urology 1999; 53: 481.
  • 5Jeremy JY, Ballard SA, Naylor AM, Miller MA, Angelini GD.Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro. Br J Urol 1997;79: 958-63.
  • 6Balard SA, Gingell CJ, Tang K, Turner LA, Price ME, Naylor AM. Effects of sildenafil on the relaxation of human corpus cavemosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozvmes. J Urol 1998; 159:2164-71.
  • 7Medina P,Segarra G, Vila JM, Domenech C, Martinez-Leon JB, Lluch S. Effects of sildenafil on human penile blood vessels.Urology 2000; 56: 539-43.
  • 8Moreira SG, Brannigan Jr RE, Spitz A, Orejuela FJ, Lipshultz LI, Kim ED. Side-effect profile of sildenafil citrate (Viagra) in clinical practice. Urology 2000; 56: 474-6.
  • 9World Health Organisation. The ICD- 10 Classification of mental and behavioral disorders: Clinical Descritions an Diagnostic Guidelines. EHO: Genova; 1992.
  • 10Berman JR, Goldstein I. Female Sexuel Dysfunction. Urology Clinics of North America 2001; 28/2: 405-16.

共引文献1

同被引文献10

引证文献2

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部